Tag: US112M
AdvanCell Closes US$112M Series C Financing
AdvanCell, a Sydney, Australia-based clinical-stage radiopharmaceutical firm growing modern most cancers therapeutics, closed a US$112m Collection C financing.…
AdvanCell, a Sydney, Australia-based clinical-stage radiopharmaceutical firm growing modern most cancers therapeutics, closed a US$112m Collection C financing.…